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Those of us interested in the extracellular matrix (ECM) are faced with significant challenges of 
definition.  ECM proteins are large, complex and assembled into crosslinked insoluble matrices.  
This has meant that defining the biochemical composition of ECMs has been difficult.  
Nonetheless, protein chemistry and molecular biology have defined many familiar ECM proteins 
– collagens, proteoglycans, laminins, thrombospondins, tenascins, fibronectins, etc.   With the 
completion of many genomes it should now be possible to develop complete “parts lists” for the 
ECM.  Such lists are needed for analyzing data from “omic” approaches such as expression 
arrays, latest-generation sequencing and proteomics.  These approaches generate long lists and it 
is typically necessary to extract from those lists the genes/proteins of interest.  Anyone who 
attempts to do this using the commonly used gene ontology (GO) categories soon discovers that 
they are largely useless for defining ECM proteins.  Many ECM proteins are unannotated and 
those which are, are sorted, with little evidence of logic or consistency, into diverse categories 
such “extracellular matrix,” “basement membrane,” “cell surface” and many others.  The human 
and mouse orthologs are often found in different categories and attempts to use GO categories to 
extract a complete list of ECM genes or proteins from a data set are unsatisfactory at best.  
 
Faced with this problem in the course of an ECM proteomics project, we decided we needed to 
develop a better list of ECM proteins (Naba et al., 2012).  This turned out to be not entirely 
straightforward.  While the familiar ECM glycoproteins, collagens and proteoglycans could be 
collected relatively easily, the standard procedures for collecting lists of homologs, using 
BLAST or domain-based searches, quickly run into problems.  ECM proteins are 
characteristically formed from multiple domains and those domains are shared among different 
ECM proteins and also with non-ECM proteins (Hohenester and Engel, 2002; Adams and Engel, 
2007).  Two obvious examples among many are EGF and FN3 domains, both very ancient 
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protein domains that predate the origins of extracellular matrix in metazoa.  They are found in 
many ECM proteins but also in diverse membrane proteins and secreted factors.  So a BLAST or 
domain search produces a confusing mix of “homologs.”  It is the domain architecture (the entire 
domain composition, number and order) that defines families of ECM proteins.   
 
Nonetheless, the domain composition of ECM proteins does offer the route to defining an 
essentially complete list of ECM proteins and sorting them from homologous but non-ECM 
proteins (i.e., those which share one or more domains with ECM proteins but are clearly not 
matrix proteins – examples would include many tyrosine kinase or phosphatase receptors or 
adhesion receptors).  We started with a list of characteristic ECM domains and used them to pull 
out all genes/proteins containing those domains from the human and mouse genomes/proteomes.  
We then culled those lists using a list of “excluding domains” to remove “contaminants” – the 
excluding list contained domains such as kinase, phosphatase and protease, chosen to eliminate 
the obvious “contaminants.”   We performed this positive/negative sweep procedure iteratively, 
checking to ensure that we collected all the ECM proteins we could think of (that meant adding 
and deleting some domains) and eliminated all the “contaminants.”  The details are given in 
Naba et al. (2012).  We ended up with a list of around 50 “including domains” and around 20 
“excluding domains” that effectively collected all known (at least to us) ECM proteins and did 
not select most growth factor and adhesion receptors.  We then screened out any proteins with 
transmembrane domains, with the exception of a few collagens.  The eventual lists (human and 
mouse) each of around 300 proteins we called the “core matrisome” (Figure 1).  These lists 
included all the known collagens, proteoglycans and well defined ECM glycoproteins along with 
additional proteins that had all the structural (domain) characteristics of ECM proteins but about 
which essentially nothing is known - presumptive novel ECM proteins. 
 
However, another question of definition arose immediately.  How do we define extracellular 
matrix?  Does it include bound growth factors or bound ECM-modifying enzymes?  And what 
about protein families such as mucins, galectins and semaphorins or proteins containing short 
stretches of collagen triple helix (C1q, collectins, ficolins, acetylcholine esterase)?   
Operationally, many of these proteins fractionate/co-purify with extracellular matrix and 
certainly contribute to its biological functions.  Scientists may differ on whether or not to include 
such protein families (and others) in the definition of ECM proteins.  So we decided to develop 
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some additional “matrisome-associated” categories, using similar strategies of “including” and 
“excluding” domains. Specifically we defined a list of secreted factors – known growth factors 
and their homologs (TGF-β, BMPs, PDGFs, FGFs, Wnts, Hedgehogs, S100 proteins, 
chemokines etc.).  We were deliberately inclusive and did not restrict these lists to growth 
factors, cytokines and chemokines known to bind to ECM proteins but also all their homologs as 
well as other families of secreted factors that might bind to ECM.  Similarly we developed a list 
of ECM regulators (MMPs and other proteases, including membrane-bound proteases such as 
ADAMs and ADAM-TS proteins as well as other protease families and protease inhibitors) and 
ECM crosslinking enzymes (transglutaminases, lysyl oxidases and prolyl hydroxylases and 
regulators of these modifiers).  Finally, we developed a list of “ECM-affiliated” proteins to 
include proteins that some might consider ECM-associated, whereas others would not.  This list 
includes mucins, C-type lectins, semaphorins, syndecans, glypicans, as well as some protein 
families that we included because some members of the family co-enriched with genuine ECM 
proteins in our experiments (annexins, galectins). 
 
We believe that the “core matrisome” categories (collagens, proteoglycans and ECM 
glycoproteins) are robust and not likely to change much with further analyses, at least for 
mammals and probably other vertebrates (other taxonomic groups clearly do contain additional 
ECM proteins).   However, the “matrisome-associated” categories (secreted factors, regulators 
and affiliated proteins) are, by their nature, less firmly established and we suspect that they may 
well evolve in light of subsequent analyses.  These latter categories were deliberately “inclusive” 
– although many proteins within those categories undoubtedly do bind reproducibly to ECM, 
others may not (see Figure 1).  Our aim was to define categories that would capture all candidate 
components of the ECM.   
 
Having generated these categorical lists (see Naba et al., 2012; Hynes and Naba, 2012 and 
http://web.mit.edu/hyneslab/matrisome/) we would like to suggest that these six subcategories 
offer a much more workable way to select out sub-lists of ECM proteins and ECM-associated 
proteins from data sets, be they derived from proteomics, genomics, expression profiling or any 
other genome-scale analyses.  We believe these lists will be straightforward to use.  We expect 
them to evolve and welcome suggestions for additions or other modifications.  It is our intention 
to maintain the “matrisome” web site and incorporate additional information in due course.  
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Figure 1.  The human matrisome and its subcategories. 
 
The core matrisome comprises three subcategories; ECM glycoproteins, collagens and 
proteoglycans, in each case defined by their domain structures (see text).  All of these proteins 
are believed to assemble into extracellular matrices of one sort or another.   
 
The three main subcategories of matrisome-associated proteins are more inclusively defined – 
they include proteins known to associate with assembled ECM as well as related proteins that 
may or may not – all were included to ensure their capture in “omic” screens of various sorts.   
 
The secreted protein category includes a list of growth factors, cytokines and other secreted 
proteins – some are known to bind to ECM at least part of the time; others are included in the 
expectation that many of them will also be discovered to bind to ECM. 
 
The ECM regulator category includes proteases, protease inhibitors and ECM crosslinking 
enzymes.  Again, many are known to bind to and modify ECM proteins and structures in 
important ways – their homologs are likely also to do so and have been included for 
completeness. 
 
The final category, designated “ECM-affiliated” includes protein families that some scientists 
(but not others) may consider as ECM proteins (e.g., mucins, C-type lectins, syndecans, 
glypicans), some that could be viewed as secreted factors but which also associate with solid-
phase complexes (e.g., semaphorins and their homologous receptors, plexins, collagen-related 
proteins such as C1q and homologs) and a few families that appear repeatedly in ECM-enriched 
preparations for currently unknown reasons (e.g., annexins, galectins).  
 
Complete lists of the proteins in each subcategory for both human and mouse, together with gene 
and protein identifiers as well as protein sequence files are given in Naba et al. (2012) and at ; 
http://web.mit.edu/hyneslab/matrisome/ and summary tables are given in Hynes and Naba, 2012. 
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